HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gina Perrella Selected Research
Gina Perrella Research Topics
Disease
6
Thrombosis (Thrombus)
04/2024 - 01/2019
2
Hemolysis
04/2024 - 01/2023
2
COVID-19
02/2023 - 12/2022
1
Sepsis (Septicemia)
02/2023
1
Hematologic Neoplasms (Hematological Malignancy)
01/2023
1
Anemia
01/2023
1
Coinfection
01/2023
1
Thrombophilia
02/2022
1
Myocardial Infarction
02/2022
1
Protein S Deficiency (Deficiency, Protein S)
02/2022
1
Protein C Deficiency
02/2022
1
Venous Thromboembolism
02/2022
1
Atherosclerotic Plaque (Atheroma)
01/2022
1
Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021
Drug/Important Bio-Agent (IBA)
5
Fibrin
IBA
12/2022 - 01/2019
3
Ligands
IBA
11/2021 - 01/2019
2
von Willebrand Factor
IBA
04/2024 - 01/2021
2
Adenosine Diphosphate (ADP)
IBA
01/2023 - 01/2022
2
Peptides (Polypeptides)
IBA
02/2022 - 01/2021
2
Collagen
IBA
02/2022 - 01/2022
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
04/2024
1
ferric chloride
IBA
04/2024
1
Hemin (Panhematin)
FDA Link
04/2024
1
Histones (Histone)
IBA
02/2023
1
Hemoglobins (Hemoglobin)
IBA
01/2023
1
Heme (Haem)
IBA
01/2023
1
Coagulants
IBA
02/2022
1
Phosphatidylserines
IBA
02/2022
1
Protein C
IBA
02/2022
1
Protein S
IBA
02/2022
1
Thrombomodulin
IBA
02/2022
1
Ticagrelor
IBA
01/2022
1
Thromboxane A2 (A2, Thromboxane)
IBA
01/2022
1
Syk Kinase
IBA
01/2022
1
Purinergic P2 Receptors (ADP Receptor)
IBA
01/2022
1
Dasatinib (BMS 354825)
FDA Link
01/2022
1
2- (2- aminocyclohexylamino)- 4- (m- tolylamino)pyrimidine- 5- carboxamide
IBA
01/2022
1
Indomethacin (Indometacin)
FDA Link
Generic
01/2022
1
ibrutinib
IBA
01/2022
1
Platelet Membrane Glycoproteins
IBA
11/2021
1
Proteins (Proteins, Gene)
FDA Link
11/2021
1
Polysaccharides (Glycans)
IBA
11/2021
1
Tyrosine (L-Tyrosine)
FDA Link
11/2021
1
Pattern Recognition Receptors
IBA
11/2021
1
Biomarkers (Surrogate Marker)
IBA
11/2021
1
platelet membrane glycoprotein VI
IBA
01/2021
1
Integrins
IBA
01/2021
1
Factor XIIIa
IBA
01/2021
1
Fibrinogen (Factor I)
FDA Link
01/2019
Therapy/Procedure
2
Therapeutics
04/2024 - 01/2023